Source: https://tendernation.io/opportunities/01a13fdd-f82b-7147-b907-4d2505856e15/austria-pharmaceutical-products-rv-produkt-zolbetuximab

Open for bids AT open procedure

# Pharmaceutical products – RV Produkt Zolbetuximab

[Landeskrankenanstalten-Betriebsgesellschaft - KABEG](https://tendernation.io/buyers/landeskrankenanstalten-betriebsgesellschaft-kabeg)

Estimated value

Not stated

Published

13 Oct 2026

Deadline

27 days left

16 Nov 2026

## Who can bid

- Open procedure

    Anyone can submit a full tender; there is no shortlisting stage.

## About this tender

Rahmenvereinbarung für das Produkt Zolbetuximab.

## CPV classification

Pharmaceutical products

Source

Tenders Electronic Daily (EU) · Notice 704942-2026

[View official notice](https://ted.europa.eu/en/notice/704942-2026)

Never miss a tender like this again

Get AI summaries, deadline alerts and a bid pipeline for tenders matched to your business. Free to start.

[Track tenders free](https://tendernation.io/register)

[Buyer profile Landeskrankenanstalten-Betriebsgesellschaft - KABEG: past awards and live tenders](https://tendernation.io/buyers/landeskrankenanstalten-betriebsgesellschaft-kabeg) [Sector More Medical equipment & pharmaceuticals tenders](https://tendernation.io/sectors/medical-equipment-pharmaceuticals)

## More tenders like this

[Pharmaceutical products – RV Produkt Pembrolizumab · Landeskrankenanstalten-Betriebsgesellschaft - KABEG · 27 days left · 16 Nov 2026](https://tendernation.io/opportunities/01a13fde-393f-71e8-bf94-719570f9202f/austria-pharmaceutical-products-rv-produkt-pembrolizumab) [Pharmaceutical products – Open-House-Verträge 2026 - Aflibercept (Kopie) · AOK Bremen/Bremerhaven · 717 days left · 5 Oct 2028](https://tendernation.io/opportunities/01a14065-4d19-716b-9b00-1253ed72281e/germany-pharmaceutical-products-open-house-vertrage-2026-aflibercept-kopi) [Pharmaceutical products – Open-House-Verträge 2025-5 - Aflibercept · AOK Bremen/Bremerhaven · 381 days left · 4 Nov 2027](https://tendernation.io/opportunities/01a140a6-60ac-73be-aacd-13a1b2c2569e/germany-pharmaceutical-products-open-house-vertrage-2025-5-aflibercept) [Pharmaceutical products – Arzneimittel mit dem Wirkstoff Ranibizumab (ATC: S01LA04) · AOK Sachsen - Anhalt · 497 days left · 28 Feb 2028](https://tendernation.io/opportunities/01a14091-5a47-7146-a676-3a0c0ff13a49/germany-pharmaceutical-products-arzneimittel-mit-dem-wirkstoff-ranibizumab) [Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Ranibizumab (ATC-Code: S01LA04). · AOK Niedersachsen. Die Gesundheitskasse. · 372 days left · 27 Oct 2027](https://tendernation.io/opportunities/01a140a7-f85c-7382-8c20-17c4108ad439/germany-pharmaceutical-products-abschluss-eines-nicht-exklusiven-rabattvertr) [Pharmaceutical products – Raamovereenkomst voor Luspatercept · AZ Sint-Jan Brugge AV · 14 days left · 3 Nov 2026](https://tendernation.io/opportunities/01a14064-dbcf-71ed-b8fc-91ade8a62ea0/belgium-pharmaceutical-products-raamovereenkomst-voor-luspatercept)